Business Daily from THE HINDU group of publications
Tuesday, Mar 13, 2007
ePaper


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Overseas Investments
Cadila Pharma to open plant in Ethiopia today

Virendra Pandit

To invest Rs 2,500 cr in expansion over 5 years


Mr Indravadan A. Modi, Chairman

Ahmedabad March 12 Cadila Pharmaceuticals Ltd is opening its first overseas manufacturing plant in Ethiopia on Tuesday, on the company's 56th anniversary, and is all set to invest Rs 2,500 crore in the next five years to expand its business globally and nationally, its Chairman, Mr Indravadan A. Modi, said today.

In an interview with Business Line, the 81-year-old pharma business patriarch of Gujarat said here that Cadila Pharma's proposed investment of Rs 2,500 crore includes the special economic zone (SEZ), which is coming up near Ahmedabad with an investment of Rs 1,800 crore.

Mr Modi said the company is also exploring possibilities of mergers and acquisitions and is considering setting up two or three plants in joint ventures abroad.

However, he decline to divulge details at this stage.

The Group, which picked up 50 per cent stake in Apollo Hospitals, Ahmedabad, is, however, not considering extending this arrangement to other Apollo facilities or other hospitals before consolidating its gains, Mr Modi said.

The Cadila plant in Ethiopia is a joint venture with a private enterprise, set up with an investment of Rs 50 crore.

"Within two years, we expect it to generate a revenue of more than Rs 100 crore per annum with an all-finished formulation business.

"We want to be among the first five pharmaceutical companies in Africa in the near future."

Cadila Pharma has so far filed 16 Drug Master Files, and this number would be doubled next year.

More Stories on : Overseas Investments | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Minor fire at Vizag Steel Plant


Reliance finds gas in 2 more east coast blocks
Rane promoters raise stake
No intention to oust Shishir from group cos, says Rahul Bajaj
IVRCL bags Rs 313-cr orders
MSTC bags `MoU Excellence' award
From forecast to foresight
CLB share transfer order flayed
From Mumbai to Omaha - dabbawallah lessons in management
Commodities account for higher share of total M&A deals
Goenkas raise stake in CESC
Mascon okays US co acquisition
Nalco signs MoU with Mines Ministry
Quipo Energy sets up centre of excellence
Cadila Pharma to open plant in Ethiopia today
Punj Lloyd arm to build chemical plant in Saudi
Glenmark inks deal with Dyax for biologics
There is life after M&A for tax holiday
Natco gesture to breast cancer patients
Himadri Sen is Ranbaxy's R&D chief
Pharma sector in throes of top-level management churn


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line